Indegene Limited IPO
- IPO Date06 Mar, 2024 to 08 Mar, 2024
- Listing Date13 May, 2024
- Face Value₹2 per share
- Issue Price₹430 to ₹452 per share
- Lot Size33 Shares
- Minimum Investment₹14,916
- Listing AtBSE, NSE
- Total Issue Size4,07,46,891 Shares
(aggregating up to ₹1841.76 Cr) - Fresh Issue1,68,14,159 Shares
(aggregating up to ₹760.00 Cr)
- Offer for Sale2,39,32,732 Shares
(aggregating up to ₹1081.76 Cr) - Issue TypeBook Built Issue IPO
- Share holding pre issue22,24,35,091
- Shareholding post issue23,92,49,250
IPO Dates
Closing Date
08 Mar, 2024
Initiation of Refunds
10 May, 2024
Listing Date
13 May, 2024
06 Mar, 2024
Opening Date
09 May, 2024
Basis of Allotment
10 May, 2024
Credit of Shares
Indegene Limited Lot Size
Investors can bid for a minimum of 33 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| S-HNI (Min) | 14 | 462 | ₹2,08,824 |
| Retail (Max) | 13 | 429 | ₹1,93,908 |
| S-HNI (Max) | 67 | 2211 | ₹9,99,372 |
| Retail (Min) | 1 | 33 | ₹14,916 |
| B-HNI (Min) | 68 | 2244 | ₹10,14,288 |
Indegene Limited Promoter Holding
>BCP Topco VII Pte. Ltd. is the promoter of the Company.
| Pre Issue Share Holding | Post Issue Share Holding |
|---|---|
| 30.71% | - |
Indegene Limited COMPANY INFORMATION
Indegene IPO is a book built issue of Rs 1,841.76 crores. The issue is a combination of fresh issue of 1.68 crore shares aggregating to Rs 760.00 crores and offer for sale of 2.39 crore shares aggregating to Rs 1,081.76 crores. Indegene IPO opens for subscription on May 6, 2024 and closes on May 8, 2024. The allotment for the Indegene IPO is expected to be finalized on Thursday, May 9, 2024. Indegene IPO will list on BSE, NSE with tentative listing date fixed as Monday, May 13, 2024. Indegene IPO price band is set at ₹430 to ₹452 per share. The minimum lot size for an application is 33 Shares. The minimum amount of investment required by retail investors is ₹14,916. The minimum lot size investment for sNII is 14 lots (462 shares), amounting to ₹208,824, and for bNII, it is 68 lots (2,244 shares), amounting to ₹1,014,288. The issue includes a reservation of up to 296,209 shares for employees offered at a discount of Rs 30 to the issue price. Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory And Securities (India) Pvt Ltd are the book running lead managers of the Indegene IPO, while Link Intime India Private Ltd is the registrar for the issue. Refer to Indegene IPO RHP for detailed information.
Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.
The company's services can be divided into following categories
- Enterprise Commercial Solutions
- Omnichannel Activation
- Enterprise Medical Solutions
- Enterprise Clinical Solutions and consultancy services
The subsidiary of the company, DT Associates Limited, provides consulting services under the "DT Consulting" brand. It helps life sciences companies manage their digital transformation efforts to ensure continued success in customer experience.
The company received the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, a recognition given by Arogya World India Trust in partnership with the Public Health Foundation of India.
As of December 31, 2023, the company had 65 clients actively engaged with its services.
As of December 31, 2023, the company employed 5,181 people worldwide. Of these, 4,461 are based in India, 530 work in North America, 105 in Europe, 73 in China, and 12 in other regions.
FAQs About Indegene Limited Ipo
Indegene Limited IPO will open on 06 Mar, 2024 and close on 08 Mar, 2024. Investors must apply within this period to participate.
The Indegene Limited IPO price band is set between ₹430.00 and ₹452.00 per share. The minimum lot size is 33, requiring an investment of at least ₹14916.00.
The Indegene Limited IPO shares are expected to be listed on 13 May, 2024, subject to regulatory approvals and final allotment.
You can track your Indegene Limited IPO application status on the registrar’s website: Link Intime or KFintech using your PAN, application number, or DP ID
The Indegene Limited IPO will be listed on major stock exchanges such as NSE and BSE, where you can trade shares once they are listed.